Cargando…
Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea
BACKGROUND AND AIMS: This study aims to investigate the cost-effectiveness of a one-time hepatitis C virus (HCV) screening and treatment program in South Korea where hepatitis B virus (HBV) prevails, in people aged 40–70, compared to current practice (no screening). METHODS: A published Markov model...
Autores principales: | Kim, Do Young, Han, Kwang-Hyub, Jun, Byungyool, Kim, Tae Hyun, Park, Sohee, Ward, Thomas, Webster, Samantha, McEwan, Phil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218507/ https://www.ncbi.nlm.nih.gov/pubmed/28060834 http://dx.doi.org/10.1371/journal.pone.0167770 |
Ejemplares similares
-
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017) -
Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C
por: McEwan, Phil, et al.
Publicado: (2015) -
Epidemiological and Clinical History of Viral Hepatitis in Korea
por: Yoon, Jung-Hwan, et al.
Publicado: (2021) -
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea
por: Kim, Do Young, et al.
Publicado: (2016) -
Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review
por: Ward, Thomas, et al.
Publicado: (2020)